Univest
Univest
  • Markets

10 Stocks to Buy Today: Pharma, Energy and PSU Names on the Radar

  • September 25, 2026
  • Posted by: Neeraj Pandey
  • Category: News
No Comments
10 Stocks to Buy Today: Pharma, Energy and PSU Names on the Radar

10 Stocks To Buy Today: Cipla, Divi’s Labs lead pharma picks. ONGC, GAIL flagged on energy. NTPC extends 33-year dividend streak. All levels from live technicals, 24 Sep close.

Quick Answer

Univest’s research desk has flagged 10 stocks to buy today spanning pharma, energy, banking and PSU names, based on the September 24, 2026 closing technicals. Cipla, Zydus Lifesciences and “Divi’s Laboratories” lead the pharma picks on healthy RSI and bullish SuperTrend signals, while Oil & Natural Gas Corporation and GAIL (India) offer steady energy exposure. Every pick below carries a technical target, a stop-loss level, and a flagged risk, since even a buy-rated stock can move against the trade.

Univest’s analysts, Ankit Jaiswal and Kunal Singla, have been watching a mixed but opportunity-rich setup heading into today’s session, with pharma and select PSU names showing the cleanest technical structure among Thursday’s closing data.

Jaiswal flagged that Cipla and the broader pharma pack are holding up relatively well even as some cyclical and industrial names cool off, while Singla pointed to NTPC’s steady dividend track record as a reason long-term investors continue to watch the counter despite its range-bound price action.

Click Here – Get Free Investment Predictions

Table of Contents

Toggle
  • 10 Stocks to Buy Today: CMP, Target and Stop-Loss
    • 1. Cipla: Pharma Major Stabilising After a Pullback
    • 2. ONGC: Steady Energy Play Within a Tight Range
    • 3. Zydus Lifesciences: Uptrend Holding Above Key Support
    • 4. GAIL India: Range-Bound but Structurally Stable
    • 5. ABB India: Contrarian Bet on Near-Term Weakness
    • 6. Karur Vysya Bank: Deeply Oversold, High-Risk Setup
    • 7. NHPC: Coiled Near Resistance, Watch for a Breakout
    • 8. H.G. Infra Engineering: Volume Spike Amid a Downtrend
    • 9. Divi’s Laboratories: Fresh 52-Week High, Momentum Intact
    • 10. NTPC: A Dividend-Anchored PSU Utility Holding
  • How Univest’s Research Desk Approaches These Picks
  • Conclusion
  • Frequently Asked Questions
    • Which are the 10 stocks to buy today, September 25, 2026?
    • How are the technical targets and stop-loss levels calculated?
    • Is Divi’s Laboratories a good buy after hitting a 52-week high?
    • Why is Karur Vysya Bank flagged despite being deeply oversold?
    • Is NTPC a good long-term buy?
    • Should I buy all 10 stocks in this list?
    • Where can I track live prices and technicals for these stocks?

10 Stocks to Buy Today: CMP, Target and Stop-Loss

Company CMP Technical Target Stop-Loss Market Cap
Cipla Rs 1399.0 Rs 1445 Rs 1358 Rs 1,12,900 crore approx.
Oil & Natural Gas Corporation Rs 239.0 Rs 246 Rs 229 Rs 3,00,600 crore approx.
Zydus Lifesciences Rs 1170.1 Rs 1210 Rs 1098 Rs 1,17,900 crore approx.
GAIL (India) Rs 173.85 Rs 179 Rs 167.6 Rs 1,14,300 crore approx.
ABB India Rs 7129.0 Track for breakout Below recent SuperTrend support Rs 1,51,200 crore approx.
Karur Vysya Bank Rs 325.0 Track for breakout Below recent SuperTrend support Rs 26,000 crore approx.
NHPC Rs 76.25 Rs 79 Rs 73.3 Rs 76,700 crore approx.
H.G. Infra Engineering Rs 468.05 Track for breakout Below recent SuperTrend support Rs 5,900 crore approx.
Divi’s Laboratories Rs 9602.0 Rs 9850 Rs 9045 Rs 2,55,000 crore approx.
NTPC Rs 326.6 Rs 335 Rs 316 Rs 3,16,900 crore approx.

Targets and stop-loss levels above are derived from live SuperTrend, ATR and moving-average data as of the September 24, 2026 close, not fixed brokerage price targets. Always observe your own stop-loss discipline.

1. Cipla: Pharma Major Stabilising After a Pullback

Cipla closed at Rs 1,399, up over 1 percent, with RSI near 51 and MACD histogram turning positive, suggesting the recent pullback from Rs 1,419 may be stabilising. The stock is holding above its 20-day SMA of Rs 1,389.

Risk to watch: The SuperTrend indicator is still flashing a sell signal at Rs 1,419, so a decisive close above that level is needed before momentum traders should add fresh positions.

2. ONGC: Steady Energy Play Within a Tight Range

ONGC gained nearly 0.9 percent to Rs 239, with RSI at 55 and a SuperTrend sell level at Rs 242.56 not far above. The stock remains within its recent 229 to 243 trading band.

Risk to watch: Crude and gas realisations remain a key swing factor for ONGC’s earnings, and global oil price volatility can move the stock sharply either way regardless of technical setup.

3. Zydus Lifesciences: Uptrend Holding Above Key Support

Zydus Lifesciences advanced 0.87 percent with RSI at nearly 54 and a positive SuperTrend signal from Rs 1,098.38, keeping the stock in an established uptrend above its 20-day SMA of Rs 1,146.91.

Risk to watch: The stock’s MACD histogram has started narrowing, an early sign that upward momentum could be losing some steam even though the broader trend stays intact.

4. GAIL India: Range-Bound but Structurally Stable

GAIL India rose 0.52 percent to Rs 173.85, sitting almost exactly on its 20-day SMA of Rs 173.38, with a bullish SuperTrend signal from Rs 167.60 keeping the near-term structure intact.

Risk to watch: MACD is marginally negative on GAIL, so the setup is more range-bound than strongly trending, and gas-pricing or subsidy-related news can move the stock outside of its technical range.

5. ABB India: Contrarian Bet on Near-Term Weakness

ABB India edged up 0.13 percent to Rs 7,129 even as its RSI at 34.5 and negative MACD histogram flag underlying weakness, with the stock trading below its 20-day SMA of Rs 7,308.75 and under a bearish SuperTrend signal at Rs 7,409.95.

Risk to watch: The technical picture here is genuinely weak, so this entry is only for investors comfortable buying into near-term softness on a fundamentally strong industrial automation franchise; a stop below Rs 6,806, the SuperTrend lower band, is essential if adding now.

Check Live Stock Fundamentals on Univest Screener

6. Karur Vysya Bank: Deeply Oversold, High-Risk Setup

Karur Vysya Bank rose marginally to Rs 325 despite an RSI of just 28, deep in oversold territory, with the stock trading well below its 20-day SMA of Rs 337.21 and under a bearish SuperTrend signal at Rs 351.48.

Risk to watch: An oversold RSI can either precede a bounce or continue lower in a genuine downtrend, so this is a higher-risk contrarian idea; a stop below the recent SuperTrend lower band of Rs 307.96 is important.

7. NHPC: Coiled Near Resistance, Watch for a Breakout

NHPC held steady near its 20-day SMA of Rs 76.12, with RSI at a neutral 48.6 and price consolidating just under the SuperTrend resistance level of Rs 79.10.

Risk to watch: The stock’s tight recent range means a breakout in either direction is likely; a close back below Rs 73.3 would invalidate the near-term bullish case.

8. H.G. Infra Engineering: Volume Spike Amid a Downtrend

H.G. Infra Engineering saw heavy volume of over 1.3 crore shares, well above typical activity, even as RSI at 44 and a bearish SuperTrend signal at Rs 483.17 suggest the stock is still working through recent weakness.

Risk to watch: This is a higher-risk technical rebound candidate given the elevated volume and downtrend signal; a stop below Rs 422, the SuperTrend lower band, limits downside if the bounce fails.

9. Divi’s Laboratories: Fresh 52-Week High, Momentum Intact

Divi’s Laboratories touched a fresh 52-week high before easing slightly to Rs 9,602, with RSI at a healthy 61 and a bullish SuperTrend signal from Rs 9,044.95 keeping the pharma major’s uptrend well intact.

Risk to watch: The MACD histogram has turned mildly negative even as price stays elevated, so some near-term consolidation after the fresh high would not be unusual.

10. NTPC: A Dividend-Anchored PSU Utility Holding

NTPC closed marginally higher at Rs 326.6, trading in a tight band between its 52-week high of Rs 414.4 and low of Rs 315.55. The PSU utility recently paid a Rs 3,393.8 crore final dividend for FY26, maintaining a 35 percent payout ratio and extending 33 consecutive years of dividend payouts.

Risk to watch: NTPC’s share price has been range-bound for months, so investors should treat this as a steady, dividend-linked utility holding rather than an expectation of a sharp near-term re-rating.

How Univest’s Research Desk Approaches These Picks

Ankit Jaiswal and Kunal Singla flag these names based on a combination of price action, RSI, MACD and SuperTrend readings pulled from the previous session’s live data, never on rumour or unverified tips. Every stock above carries a specific, stated risk, because even names with a bullish technical setup can reverse on broader market moves, sector news, or company-specific developments.

Investors should treat the technical targets and stop-loss levels above as a starting framework, not a guarantee, and are encouraged to observe stop-loss discipline strictly, position size according to their own risk appetite, and consult a SEBI-registered investment adviser before acting on any of these ideas.

Download the Univest iOS App or Univest Android App to track your portfolio on the go.

Conclusion

Today’s 10 stocks to buy today lean toward pharma and steady PSU energy names, with a couple of higher-risk contrarian setups in banking and industrials for investors comfortable with more volatility. As always, position sizing and stop-loss discipline matter as much as the pick itself.

The information in this article is for educational purposes only and must not be treated as investment advice. Stock markets are subject to risk, and past performance is not indicative of future results. Please verify all data independently and consult a registered investment adviser before making any investment decision. Univest Communications Private Limited, SEBI Registered Research Analyst, Registration No. INH000013776.

Frequently Asked Questions

Which are the 10 stocks to buy today, September 25, 2026?

Ans. Today’s list includes Cipla, ONGC, Zydus Lifesciences, GAIL India, ABB India, Karur Vysya Bank, NHPC, H.G. Infra Engineering, Divi’s Laboratories, and NTPC, each flagged for a different technical or fundamental reason.

How are the technical targets and stop-loss levels calculated?

Ans. Targets and stop-loss levels are derived from live SuperTrend bands, ATR and moving-average data from the most recent session’s close, not from fixed brokerage price targets.

Is Divi’s Laboratories a good buy after hitting a 52-week high?

Ans. Divi’s Laboratories shows a healthy RSI near 61 and a bullish SuperTrend signal, suggesting the uptrend remains intact, though some near-term consolidation after a fresh high would not be unusual.

Why is Karur Vysya Bank flagged despite being deeply oversold?

Ans. An RSI near 28 signals oversold conditions that can precede a bounce, but the stock remains under a bearish SuperTrend signal, making this a higher-risk contrarian idea rather than a clear trend-following buy.

Is NTPC a good long-term buy?

Ans. NTPC has a 33-year track record of consistent dividend payments and a 35 percent FY26 payout ratio, making it more suited to long-term, income-focused investors than to those seeking a sharp near-term price move.

Should I buy all 10 stocks in this list?

Ans. No. Each stock carries its own catalyst and risk; investors should evaluate each pick individually against their own risk appetite, portfolio allocation, and financial goals rather than buying the full list.

Where can I track live prices and technicals for these stocks?

Ans. You can check live prices, technical indicators, and fundamentals for all of today’s picks using the Univest Screener.



10 Stocks to Buy Today Cipla divis laboratories NTPC
Author: Neeraj Pandey
Neeraj Pandey is a Financial Content Writer at Univest, covering Indian equity markets with a specialisation in quarterly earnings previews and analyst consensus analysis. His published work tracks Q4 FY26 results across 10+ sectors — from IT heavyweights like Infosys and TCS to PSUs like Coal India and Balmer Lawrie, and mid-caps like Neuland Laboratories, MCX, and Whirlpool of India. His writing approach is data-first: every article anchors on NSE/BSE filings, analyst consensus estimates (revenue, PAT, EBITDA margins), 52-week price context, and YoY/QoQ comparisons — giving retail investors the same structured framework institutional desks use before an earnings event. He combines SEO-optimised structure with rigorous data sourcing, ensuring each preview ranks for investor search intent while meeting SEBI editorial standards. All articles are reviewed by Univest's in-house equity research team, led by Ankit Jaiswal, Senior Equity Research Analyst, to meet SEBI editorial standards.

Leave a Reply Cancel reply